{"id":"https://openalex.org/W7122829222","doi":"https://doi.org/10.1093/ofid/ofaf695.1392","title":"P-1199. Well-Balanced Dual-Targeting of Gepotidacin against Neisseria gonorrhoeae Gyrase and Topoisomerase IV in Cells and in vitro","display_name":"P-1199. Well-Balanced Dual-Targeting of Gepotidacin against Neisseria gonorrhoeae Gyrase and Topoisomerase IV in Cells and in vitro","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7122829222","doi":"https://doi.org/10.1093/ofid/ofaf695.1392"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofaf695.1392","doi":"https://doi.org/10.1093/ofid/ofaf695.1392","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaf695.1392","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofaf695.1392","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003400724","display_name":"Alexandria A. Oviatt","orcid":"https://orcid.org/0000-0002-4629-7642","observed_orcids":["https://orcid.org/0000-0002-4629-7642"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandria A Oviatt","raw_affiliation_strings":["Vanderbilt University School of Medicine , Nashville, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University School of Medicine , Nashville, Tennessee","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006734291","display_name":"Jessica A. Collins","orcid":"https://orcid.org/0000-0002-4077-1016","observed_orcids":["https://orcid.org/0000-0002-4077-1016"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica A Collins","raw_affiliation_strings":["Vanderbilt University School of Medicine , Nashville, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University School of Medicine , Nashville, Tennessee","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122759454","display_name":"Jianzhong Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jianzhong Huang","raw_affiliation_strings":["GlaxoSmithKline, Collegeville , Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville , Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114132981","display_name":"Karen Mattern","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Mattern","raw_affiliation_strings":["GlaxoSmithKline, Collegeville , Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville , Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085910125","display_name":"Pan F. Chan","orcid":"https://orcid.org/0009-0000-0789-632X","observed_orcids":["https://orcid.org/0009-0000-0789-632X"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pan Chan","raw_affiliation_strings":["GlaxoSmithKline, Collegeville , Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville , Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041320360","display_name":"Neil Osheroff","orcid":"https://orcid.org/0000-0002-2550-4884","observed_orcids":["https://orcid.org/0000-0002-2550-4884","https://orcid.org/0000-0003-0355-4773"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil Osheroff","raw_affiliation_strings":["Vanderbilt University School of Medicine , Nashville, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University School of Medicine , Nashville, Tennessee","institution_ids":["https://openalex.org/I200719446"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.02328468,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.8852999806404114,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.8852999806404114,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.056699998676776886,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gepotidacin","display_name":"gepotidacin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/neisseria-gonorrhoeae","display_name":"Neisseria gonorrhoeae","score":0.9980000257492065},{"id":"https://openalex.org/keywords/gyrase","display_name":"gyrase","score":0.8650000095367432},{"id":"https://openalex.org/keywords/topoisomerase-iv","display_name":"topoisomerase IV","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dual-targeting","display_name":"dual targeting","score":0.7139999866485596},{"id":"https://openalex.org/keywords/fluoroquinolone-resistance","display_name":"fluoroquinolone resistance","score":0.8569999933242798},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.6359999775886536},{"id":"https://openalex.org/keywords/dna-supercoiling","display_name":"DNA supercoiling","score":0.8149999976158142},{"id":"https://openalex.org/keywords/dna-decatenation","display_name":"DNA decatenation","score":0.8539999723434448},{"id":"https://openalex.org/keywords/gonorrhea","display_name":"gonorrhea","score":0.5320000052452087}],"concepts":[{"id":"https://openalex.org/C2779166590","wikidata":"https://www.wikidata.org/wiki/Q131129","display_name":"Neisseria gonorrhoeae","level":2,"score":0.9128000140190125},{"id":"https://openalex.org/C167125095","wikidata":"https://www.wikidata.org/wiki/Q70551687","display_name":"DNA gyrase","level":4,"score":0.8689000010490417},{"id":"https://openalex.org/C2777112418","wikidata":"https://www.wikidata.org/wiki/Q7824976","display_name":"Topoisomerase IV","level":5,"score":0.6948000192642212},{"id":"https://openalex.org/C2778082588","wikidata":"https://www.wikidata.org/wiki/Q101896","display_name":"Gonorrhea","level":3,"score":0.6626999974250793},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.5034999847412109},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.4869999885559082},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44620001316070557},{"id":"https://openalex.org/C2779922871","wikidata":"https://www.wikidata.org/wiki/Q426549","display_name":"Quinolone","level":3,"score":0.38609999418258667},{"id":"https://openalex.org/C2777272437","wikidata":"https://www.wikidata.org/wiki/Q131238","display_name":"Bacillus subtilis","level":3,"score":0.3481999933719635},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3463999927043915},{"id":"https://openalex.org/C2778616834","wikidata":"https://www.wikidata.org/wiki/Q281044","display_name":"Topoisomerase inhibitor","level":4,"score":0.328000009059906},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.32499998807907104},{"id":"https://openalex.org/C2909760446","wikidata":"https://www.wikidata.org/wiki/Q12198","display_name":"Sexually transmitted disease","level":4,"score":0.3215000033378601},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3003000020980835},{"id":"https://openalex.org/C2777954195","wikidata":"https://www.wikidata.org/wiki/Q132209","display_name":"Neisseria","level":3,"score":0.2924000024795532},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2915000021457672},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.28999999165534973},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2784999907016754},{"id":"https://openalex.org/C2776520383","wikidata":"https://www.wikidata.org/wiki/Q421713","display_name":"Ceftriaxone","level":3,"score":0.2667999863624573},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.25529998540878296},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2542000114917755}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/ofid/ofaf695.1392","doi":"https://doi.org/10.1093/ofid/ofaf695.1392","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaf695.1392","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12792421","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12792421/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofaf695.1392","doi":"https://doi.org/10.1093/ofid/ofaf695.1392","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaf695.1392","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7726739645004272,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Gonorrhea,":[2],"a":[3,12,61,65,86,165,258],"sexually":[4],"transmitted":[5],"infection":[6],"caused":[7],"by":[8,289,309],"Neisseria":[9],"gonorrhoeae,":[10],"poses":[11],"significant":[13],"public":[14],"health":[15],"challenge.":[16],"Fluoroquinolones":[17],"(FQs)":[18],"once":[19],"served":[20],"as":[21],"first-line":[22],"therapy":[23],"for":[24,99,261],"gonorrhea,":[25],"but":[26,77],"rising":[27],"resistance":[28,37],"led":[29],"to":[30,52,95,204,247,331],"their":[31,43],"removal":[32],"from":[33,40,83],"treatment":[34,68],"guidelines.":[35],"FQ":[36],"stems":[38],"primarily":[39,229,305],"mutations":[41,253],"in":[42,164,210,241,254,316,321,362],"enzyme":[44],"targets,":[45],"gyrase":[46,73,221,237,293,324],"and":[47,74,80,159,201,214,222,238,286,294,303,326,352],"topoisomerase":[48,75,223,239,295,327],"IV.":[49,224],"In":[50,85],"response":[51],"the":[53,115,135,148,176,206,272,333,339,350],"growing":[54],"threat":[55],"of":[56,114,134,208,236,341,354,356],"antibacterial":[57],"resistance,":[58],"gepotidacin":[59,92,117,190,209,232,248,251,282,342,357],"(Fig.),":[60],"first-in-class":[62],"triazaacenaphthylene,":[63],"offers":[64],"promising":[66],"new":[67,105],"strategy.":[69],"Gepotidacin":[70,265],"also":[71,266],"targets":[72],"IV":[76,240,328],"is":[78,186],"chemically":[79],"mechanistically":[81],"distinct":[82],"FQs.":[84],"phase":[87],"3":[88],"clinical":[89],"trial,":[90],"oral":[91],"demonstrated":[93],"non-inferiority":[94],"ceftriaxone":[96],"+":[97],"azithromycin":[98],"uncomplicated":[100],"urogenital":[101],"gonorrhea":[102],"with":[103,118,129,147,192,278],"no":[104],"safety":[106],"concerns":[107],"[Ross":[108],"et":[109],"al":[110],"(2025)":[111],"Lancet].":[112],"Structure":[113],"triazaacenaphthylene":[116,125],"key":[119,317],"pharmacophoric":[120],"elements":[121],"shown:":[122],"left-hand":[123],"side":[124,161],"that":[126,145,162,172],"pi-pi":[127],"stacks":[128],"two":[130],"central":[131,140],"base":[132],"pairs":[133],"stretched":[136],"DNA":[137,284,307],"(LHS,":[138],"blue),":[139],"linker":[141],"(black),":[142],"basic":[143],"amine":[144],"interacts":[146,191],"aspartic":[149,318],"acid":[150,319],"(N.":[151],"gonorrhoeae":[152,195,212,220,243,292,323],"GyrA":[153,168],"D90":[154],"or":[155,169],"ParC":[156,170],"D86;":[157],"red),":[158],"right-hand":[160],"binds":[163],"largely":[166],"hydrophobic":[167],"pocket":[171],"opens":[173],"up":[174],"on":[175,217],"dimer":[177],"interface":[178],"(RHS,":[179],"green).":[180],"Methods":[181],"Despite":[182],"this":[183],"success,":[184],"little":[185],"known":[187],"about":[188],"how":[189],"its":[193,215,279,359],"N.":[194,211,219,242,291,322],"targets.":[196],"Thus,":[197],"we":[198],"undertook":[199],"genetic":[200],"biochemical":[202],"studies":[203],"determine":[205],"targeting":[207,351],"cells":[213,270],"effects":[216],"purified":[218,290],"Results":[225],"Unlike":[226],"FQs,":[227],"which":[228],"target":[230],"gyrase,":[231],"displayed":[233],"well-balanced":[234],"dual-targeting":[235],"cells.":[244],"Reduced":[245],"susceptibility":[246],"required":[249],"concurrent":[250],"target-specific":[252],"both":[255,310,344],"enzymes,":[256],"predicting":[257],"low":[259,300],"propensity":[260],"developing":[262],"target-mediated":[263],"resistance.":[264],"maintained":[267],"activity":[268,340],"against":[269,343],"harboring":[271],"most":[273,334],"common":[274],"FQ-resistant":[275],"mutations.":[276],"Consistent":[277],"cellular":[280],"dual-targeting,":[281],"inhibited":[283],"supercoiling":[285],"decatenation":[287],"catalyzed":[288],"IV,":[296],"respectively,":[297],"at":[298,312],"similar":[299],"\u00b5M":[301],"concentrations,":[302],"induced":[304],"single-stranded":[306],"breaks":[308],"enzymes":[311],"comparable":[313],"concentrations.":[314],"Mutations":[315],"residues":[320],"(GyrAD90)":[325],"(ParCD86),":[329],"predicted":[330],"mediate":[332],"important":[335],"gepotidacin-protein":[336],"interactions,":[337],"diminished":[338],"enzymes.":[345],"Conclusion":[346],"These":[347],"insights":[348],"into":[349],"mechanism":[353],"action":[355],"support":[358],"potential":[360],"use":[361],"treating":[363],"gonorrhea.":[364],"Disclosures":[365],"Jianzhong":[366],"Huang,":[367],"PhD,":[368,378],"GlaxoSmithKline:":[369,374,379],"Employee":[370,375,380],"Karen":[371],"Mattern,":[372],"MSc,":[373],"Pan":[376],"Chan,":[377]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2026-01-13T00:00:00"}